Medistim Asa Stock Cash Per Share
| MEDI Stock | NOK 148.00 7.00 4.96% |
Medistim ASA fundamentals help investors to digest information that contributes to Medistim ASA's financial success or failures. It also enables traders to predict the movement of Medistim Stock. The fundamental analysis module provides a way to measure Medistim ASA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medistim ASA stock.
Medistim |
Medistim ASA Company Cash Per Share Analysis
Medistim ASA's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Medistim ASA Cash Per Share | 2.99 X |
Most of Medistim ASA's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medistim ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Medistim ASA has a Cash Per Share of 2.99 times. This is 31.26% lower than that of the Healthcare sector and 14.56% higher than that of the Medical Devices industry. The cash per share for all Norway stocks is 40.32% higher than that of the company.
Medistim Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medistim ASA's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medistim ASA could also be used in its relative valuation, which is a method of valuing Medistim ASA by comparing valuation metrics of similar companies.Medistim ASA is currently under evaluation in cash per share category among its peers.
Medistim Fundamentals
| Return On Equity | 0.31 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 4.12 B | |||
| Shares Outstanding | 18.26 M | |||
| Shares Owned By Insiders | 14.97 % | |||
| Shares Owned By Institutions | 73.95 % | |||
| Price To Earning | 36.32 X | |||
| Price To Book | 12.24 X | |||
| Price To Sales | 9.15 X | |||
| Revenue | 417.82 M | |||
| Gross Profit | 320.7 M | |||
| EBITDA | 137.68 M | |||
| Net Income | 90.9 M | |||
| Cash And Equivalents | 129.49 M | |||
| Cash Per Share | 2.99 X | |||
| Total Debt | 17.08 M | |||
| Debt To Equity | 3.40 % | |||
| Current Ratio | 3.68 X | |||
| Book Value Per Share | 18.94 X | |||
| Cash Flow From Operations | 128.14 M | |||
| Earnings Per Share | 5.34 X | |||
| Target Price | 290.0 | |||
| Number Of Employees | 116 | |||
| Beta | 0.75 | |||
| Market Capitalization | 4.24 B | |||
| Total Asset | 403.24 M | |||
| Working Capital | 93 M | |||
| Current Asset | 136 M | |||
| Current Liabilities | 43 M | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 2.62 % | |||
| Net Asset | 403.24 M | |||
| Last Dividend Paid | 3.75 |
About Medistim ASA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medistim ASA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medistim ASA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medistim ASA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Medistim Stock
Medistim ASA financial ratios help investors to determine whether Medistim Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medistim with respect to the benefits of owning Medistim ASA security.